Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Fanhua Inc is an insurance brokers business based in the US. Fanhua shares (FANH) are listed on the NASDAQ and all prices are listed in US Dollars. Fanhua employs 4,926 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$11.82|
|52-week range||$10.83 - $17.88|
|50-day moving average||$13.92|
|200-day moving average||$14.20|
|Wall St. target price||$14.50|
|Dividend yield||$4.929 (42.09%)|
|Earnings per share (TTM)||$0.93|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-15)||-1.50%|
|1 month (2021-08-20)||-18.65%|
|3 months (2021-06-22)||-21.25%|
|6 months (2021-03-22)||-22.08%|
|1 year (2020-09-22)||-34.48%|
|2 years (2019-09-20)||-57.28%|
|3 years (2018-09-21)||28.4|
|5 years (2016-09-22)||45.21%|
Valuing Fanhua stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fanhua's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fanhua's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Fanhua shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Fanhua's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $354.9 million.
The EBITDA is a measure of a Fanhua's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.4 billion|
|Operating margin TTM||9.76%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||6.54%|
|Return on equity TTM||16.67%|
|Market capitalisation||$590.6 million|
TTM: trailing 12 months
There are currently 1.8 million Fanhua shares held short by investors – that's known as Fanhua's "short interest". This figure is 1.2% up from 1.7 million last month.
There are a few different ways that this level of interest in shorting Fanhua shares can be evaluated.
Fanhua's "short interest ratio" (SIR) is the quantity of Fanhua shares currently shorted divided by the average quantity of Fanhua shares traded daily (recently around 53962.860650706). Fanhua's SIR currently stands at 32.58. In other words for every 100,000 Fanhua shares traded daily on the market, roughly 32580 shares are currently held short.
However Fanhua's short interest can also be evaluated against the total number of Fanhua shares, or, against the total number of tradable Fanhua shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fanhua's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Fanhua shares in existence, roughly 30 shares are currently held short) or 0.0449% of the tradable shares (for every 100,000 tradable Fanhua shares, roughly 45 shares are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Fanhua.
Find out more about how you can short Fanhua stock.
Dividend payout ratio: 71.22% of net profits
Recently Fanhua has paid out, on average, around 71.22% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.12% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fanhua shareholders could enjoy a 5.12% return on their shares, in the form of dividend payments. In Fanhua's case, that would currently equate to about $4.929 per share.
Fanhua's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Fanhua's most recent dividend payout was on 22 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 September 2021 (the "ex-dividend date").
Over the last 12 months, Fanhua's shares have ranged in value from as little as $10.83 up to $17.875. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fanhua's is 0.5311. This would suggest that Fanhua's shares are less volatile than average (for this exchange).
Fanhua Inc. , together with its subsidiary, distributes insurance products in China. It operates through two segments, Insurance Agency and Claims Adjusting. The Insurance Agency segment provides property and casualty insurance products that primarily include individual accident, travel, homeowner, and indemnity medical insurance products; and life insurance products, such as individual health, individual whole life, individual term life, individual endowment life, and individual annuity, as well as participating insurance products. The Claims Adjusting segment offers pre-underwriting survey, claims adjusting, residual value disposal, loading and unloading supervision, and consulting services. The company also operates baoxian. com, an online insurance platform, which allows customers to search for, and purchase a range of insurance products; Lan Zhanggui, an internet-based all-in-one application; and ehuzhu.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
Everything we know about the Wetouch Technology IPO, plus information on how to buy in.
Everything we know about the Life Time Group Holdings IPO, plus information on how to buy in.
Everything we know about the Slinger Bag IPO, plus information on how to buy in.
Everything we know about the NSTS Bancorp IPO, plus information on how to buy in.
Everything we know about the Volcon IPO, plus information on how to buy in.
Everything we know about the Thomas James Homes IPO, plus information on how to buy in.
Everything we know about the FGI Industries IPO, plus information on how to buy in.
Everything we know about the Zhong Yang Financial Group IPO, plus information on how to buy in.
Everything we know about the Exscientia Ltd IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.